Significant growth in demand for pharmaceuticals, such as GLP-1s, increased R&D spending for autonomous manufacturing, and the increased presence of contract manufacturers globally are among the key ...

Nagy said pharmaceutical and fine chemical companies face process development challenges due to limited ... application of cutting-edge crystallization monitoring, modeling and control solutions. We ...

Historically, pharmaceutical products have been ... changes will require significant alterations to the control strategy for the process and possibly re-validation of the entire process 3.